BeOne Medicines AG
SWB:49BA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BeOne Medicines AG
SWB:49BA
|
CH |
|
W
|
Winchester Energy Ltd
OTC:WCHEF
|
AU |
|
K
|
Kadimastem Ltd
TASE:KDST
|
IL |
|
Freedom Internet Group Inc
OTC:FIGI
|
PR |
|
Fujifilm Holdings Corp
TSE:4901
|
JP |
|
G
|
Grempco SA
WSE:GRM
|
PL |
|
Trada Alam Minera Tbk PT
IDX:TRAM
|
ID |
|
Satellos Bioscience Inc
TSX:MSCL
|
CA |
|
H
|
Health In Tech Inc
NASDAQ:HIT
|
US |
|
B
|
Blender Financial Technologies Ltd
TASE:BLND
|
IL |
|
P
|
Preferred Bank
F:1IU
|
US |
|
G
|
Gentili Mosconi SpA
MIL:GM
|
IT |
|
Tung Lok Restaurants (2000) Ltd
SGX:540
|
SG |
|
T
|
Tongyang Pile Inc
KOSDAQ:228340
|
KR |
|
T
|
Tamburi Investment Partners SpA
F:T1I
|
IT |
|
Orezone Gold Corp
F:OEX
|
CA |
|
T
|
Take-Two Interactive Software Inc
DUS:TKE
|
US |
|
R
|
Rich Sport PCL
SET:RSP
|
TH |
|
F
|
Frey SA
PAR:FREY
|
FR |
|
S
|
Sixty Six Capital Inc
CNSX:SIX
|
CA |
|
KGHM Polska Miedz SA
WSE:KGH
|
PL |
|
Thungela Resources Ltd
F:6UP
|
ZA |
|
Ladang Baja Murni Tbk PT
IDX:LABA
|
ID |
Wall St Price Targets
49BA Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for 49BA is 446.98 EUR with a low forecast of 373.04 EUR and a high forecast of 576.26 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 49BA's stock price target?
Price Target
446.98
EUR
According to Wall Street analysts, the average 1-year price target for 49BA is 446.98 EUR with a low forecast of 373.04 EUR and a high forecast of 576.26 EUR.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.